Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05985473 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement

Study acronym: REFINED
StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 15, 2024 (before its estimated September 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Feb 2024); last known: Recruiting
  2. Start date changed from estimate of Mar 2024 to Mar 6, 2024v6
  3. Start date: Jan 2024 to Mar 2024v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 20, 2023 to Jan 2024
    • Site details revised
    v4
  5. Start date: Oct 20, 2023 to Dec 20, 2023v3
  6. Start date: Sep 15, 2023 to Oct 20, 2023v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.
Trial Details
NCT Number NCT05985473
Lead Sponsor Institut Pasteur
Conditions
(from sponsor)		 Deafness Neurosensory
Related terms Hearing Loss, Hearing Loss, Sensorineural
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov